116 related articles for article (PubMed ID: 22297111)
61. Aplysamine-1 and related analogs as histamine H3 receptor antagonists.
Swanson DM; Wilson SJ; Boggs JD; Xiao W; Apodaca R; Barbier AJ; Lovenberg TW; Carruthers NI
Bioorg Med Chem Lett; 2006 Feb; 16(4):897-900. PubMed ID: 16300945
[TBL] [Abstract][Full Text] [Related]
62. Investigation of the histamine H3 receptor binding site. Design and synthesis of hybrid agonists with a lipophilic side chain.
Ishikawa M; Watanabe T; Kudo T; Yokoyama F; Yamauchi M; Kato K; Kakui N; Sato Y
J Med Chem; 2010 Sep; 53(17):6445-56. PubMed ID: 20690643
[TBL] [Abstract][Full Text] [Related]
63. Lead optimization of thiazolo[5,4-c]piperidines: 3-cyclobutoxy linker as a key spacer for H(3)R inverse agonists.
Provins L; Denonne F; Célanire S; Christophe B; Defays S; Delaunoy C; Delporte ML; Demaude T; Durieu V; Gillard M; Hubert D; Lamberty Y; Lorent G; Valade A; Vanbellinghen A; Van Houtvin N
ChemMedChem; 2012 Dec; 7(12):2087-92. PubMed ID: 23042668
[TBL] [Abstract][Full Text] [Related]
64. Structurally novel histamine H3 receptor antagonists GSK207040 and GSK334429 improve scopolamine-induced memory impairment and capsaicin-induced secondary allodynia in rats.
Medhurst AD; Briggs MA; Bruton G; Calver AR; Chessell I; Crook B; Davis JB; Davis RP; Foley AG; Heslop T; Hirst WD; Medhurst SJ; Ociepka S; Ray A; Regan CM; Sargent B; Schogger J; Stean TO; Trail BK; Upton N; White T; Orlek B; Wilson DM
Biochem Pharmacol; 2007 Apr; 73(8):1182-94. PubMed ID: 17276409
[TBL] [Abstract][Full Text] [Related]
65. N-substituted piperidinyl alkyl imidazoles: discovery of methimepip as a potent and selective histamine H3 receptor agonist.
Kitbunnadaj R; Hashimoto T; Poli E; Zuiderveld OP; Menozzi A; Hidaka R; de Esch IJ; Bakker RA; Menge WM; Yamatodani A; Coruzzi G; Timmerman H; Leurs R
J Med Chem; 2005 Mar; 48(6):2100-7. PubMed ID: 15771452
[TBL] [Abstract][Full Text] [Related]
66. Role of hydrophobic substituents on the terminal nitrogen of histamine in receptor binding and agonist activity: development of an orally active histamine type 3 receptor agonist and evaluation of its antistress activity in mice.
Ishikawa M; Shinei R; Yokoyama F; Yamauchi M; Oyama M; Okuma K; Nagayama T; Kato K; Kakui N; Sato Y
J Med Chem; 2010 May; 53(9):3840-4. PubMed ID: 20384344
[TBL] [Abstract][Full Text] [Related]
67. Histamine H3 receptor antagonists: from target identification to drug leads.
Bonaventure P; Letavic M; Dugovic C; Wilson S; Aluisio L; Pudiak C; Lord B; Mazur C; Kamme F; Nishino S; Carruthers N; Lovenberg T
Biochem Pharmacol; 2007 Apr; 73(8):1084-96. PubMed ID: 17129577
[TBL] [Abstract][Full Text] [Related]
68. 1-[2-(1-Cyclobutylpiperidin-4-yloxy)-6,7-dihydro-4H-thiazolo[5,4-c]pyridin-5-yl]propan-1-one: a Histamine H
Shinde AK; Badange RK; Reballi V; Achanta PK; Bojja K; Manchineella S; Rao Muddana N; Subramanian R; Choudary Palacharla R; Benade V; Jayarajan P; Thentu JB; Lingavarapu BB; Yarra S; Kagita N; Rao Doguparthi M; Mohammed AR; Nirogi R
ChemMedChem; 2022 Feb; 17(3):e202100583. PubMed ID: 34761873
[TBL] [Abstract][Full Text] [Related]
69. Structural requirements for inverse agonism and neutral antagonism of indole-, benzimidazole-, and thienopyrrole-derived histamine H4 receptor ligands.
Schneider EH; Strasser A; Thurmond RL; Seifert R
J Pharmacol Exp Ther; 2010 Aug; 334(2):513-21. PubMed ID: 20484153
[TBL] [Abstract][Full Text] [Related]
70. H3 receptor antagonists/inverse agonists as anti-obesity agents.
Hancock AA
Curr Opin Investig Drugs; 2003 Oct; 4(10):1190-7. PubMed ID: 14649210
[TBL] [Abstract][Full Text] [Related]
71. Search for novel leads for histamine H3-receptor antagonists: oxygen-containing derivatives.
Stark H; Hüls A; Ligneau X; Arrang JM; Schwartz JC; Schunack W
Pharmazie; 1997 Jul; 52(7):495-500. PubMed ID: 9266588
[TBL] [Abstract][Full Text] [Related]
72. Mutations of Cys-17 and Ala-271 in the human histamine H2 receptor determine the species selectivity of guanidine-type agonists and increase constitutive activity.
Preuss H; Ghorai P; Kraus A; Dove S; Buschauer A; Seifert R
J Pharmacol Exp Ther; 2007 Jun; 321(3):975-82. PubMed ID: 17347323
[TBL] [Abstract][Full Text] [Related]
73. Histamine H3 receptor agonists.
De Esch IJ; Belzar KJ
Mini Rev Med Chem; 2004 Nov; 4(9):955-63. PubMed ID: 15544556
[TBL] [Abstract][Full Text] [Related]
74. Discovery of (1R,6S)-5-[4-(1-cyclobutyl-piperidin-4-yloxy)-phenyl]-3,4-diaza-bicyclo[4.1.0]hept-4-en-2-one (R,S-4a): histamine H(3) receptor inverse agonist demonstrating potent cognitive enhancing and wake promoting activity.
Hudkins RL; Josef KA; Becknell NC; Aimone LD; Lyons JA; Mathiasen JR; Gruner JA; Raddatz R
Bioorg Med Chem Lett; 2014 Mar; 24(5):1303-6. PubMed ID: 24513042
[TBL] [Abstract][Full Text] [Related]
75. Synthesis, absolute configuration, stereoselectivity, and receptor selectivity of (alpha R, beta S)-alpha,beta-dimethylhistamine, a novel high potent histamine H3 receptor agonist.
Lipp R; Arrang JM; Garbarg M; Luger P; Schwartz JC; Schunack W
J Med Chem; 1992 Nov; 35(23):4434-41. PubMed ID: 1280301
[TBL] [Abstract][Full Text] [Related]
76. SAR exploration of the non-imidazole histamine H
Wágner G; Mocking TAM; Ma X; Slynko I; Da Costa Pereira D; Breeuwer R; Rood NJN; van der Horst C; Vischer HF; de Graaf C; de Esch IJP; Wijtmans M; Leurs R
Arch Pharm (Weinheim); 2023 Jan; 356(1):e2200451. PubMed ID: 36310109
[TBL] [Abstract][Full Text] [Related]
77. Ergoline-derived inverse agonists of the human h3 receptor for the treatment of narcolepsy.
Auberson YP; Troxler T; Zhang X; Yang CR; Fendt M; Feuerbach D; Liu YC; Lagu B; Lerchner A; Perrone M; Lei L; Zhang C; Wang C; Wang TL; Bock MG
ChemMedChem; 2014 Aug; 9(8):1683-96. PubMed ID: 24850792
[TBL] [Abstract][Full Text] [Related]
78. Assessment of pharmacology and potential anti-obesity properties of H3 receptor antagonists/inverse agonists.
Hancock AA; Brune ME
Expert Opin Investig Drugs; 2005 Mar; 14(3):223-41. PubMed ID: 15833055
[TBL] [Abstract][Full Text] [Related]
79. Histamine H(3) receptor (H(3)R) antagonists and inverse agonists in the treatment of sleep disorders.
Broderick M; Masri T
Curr Pharm Des; 2011; 17(15):1426-9. PubMed ID: 21476958
[TBL] [Abstract][Full Text] [Related]
80. JNJ10181457, a histamine H3 receptor inverse agonist, regulates in vivo microglial functions and improves depression-like behaviours in mice.
Iida T; Yoshikawa T; Kárpáti A; Matsuzawa T; Kitano H; Mogi A; Harada R; Naganuma F; Nakamura T; Yanai K
Biochem Biophys Res Commun; 2017 Jul; 488(3):534-540. PubMed ID: 28526411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
